External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e78225
Publisher
Public Library of Science (PLoS)
Online
2013-11-05
DOI
10.1371/journal.pone.0078225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
- (2013) Christoph Tinchon et al. ACTA ONCOLOGICA
- Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
- (2013) J Szkandera et al. BRITISH JOURNAL OF CANCER
- A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
- (2013) G Absenger et al. BRITISH JOURNAL OF CANCER
- Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
- (2013) M Pichler et al. BRITISH JOURNAL OF CANCER
- A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
- (2012) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
- (2012) Yanwen Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
- (2012) De-shen Wang et al. MEDICAL ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer
- (2011) T. A. Zikos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
- (2009) Satoshi Teramukai et al. EUROPEAN JOURNAL OF CANCER
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started